JDD August Highlights – Special Focus: Psoriasis
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps …
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps … Continue reading "JDD August Highlights – Special Focus: Psoriasis"
There is more than meets the eye when it comes to diagnosing dermatologic disease. At the most recent Skin of Color Update conference in New York City, co-chair Dr. Andrew Alexis gave a case-based presentation on dermatologic clues to systemic disease in patients with skin of color. The cases highlighted how subtle pigmentary and textural changes in the skin can be the first presenting sign of … 
At the most recent Skin of Color Update conference in New York City, Dr. Cheryl Burgess and Dr. Michelle Henry shared their perspectives on the evolving landscape of cosmetic dermatology, highlighting both established treatments and cutting-edge innovations that are reshaping aesthetic care for patients with skin of color.
Expanding Indications and FDA Approvals
Dr. Burgess, who has witnessed th … 
Antihistamines, particularly second-generation histamine H1-receptor antagonists, are widely used in dermatology due to their antihistaminic activity and favorable safety profile characterized by minimal sedation compared with first-generation agents. They primarily act as peripheral H1-receptor antagonists, reducing histamine-mediated effects such as vasodilation, increased vascular permeability, … 
At the 2026 ODAC Dermatology Conference in Orlando, Florida, Dr. Olayemi Sokumbi, MD delivered a masterclass on clinicopathologic correlation. A board-certified dermatologist and dermatopathologist widely recognized for her expertise in complex medical dermatology, Dr. Sokumbi showcased her special interest in diagnostic dilemmas in her talk. She emphasized the critical role of clinicopathologic c …